IL88619A0 - Non-peptidic renin inhibitors - Google Patents

Non-peptidic renin inhibitors

Info

Publication number
IL88619A0
IL88619A0 IL88619A IL8861988A IL88619A0 IL 88619 A0 IL88619 A0 IL 88619A0 IL 88619 A IL88619 A IL 88619A IL 8861988 A IL8861988 A IL 8861988A IL 88619 A0 IL88619 A0 IL 88619A0
Authority
IL
Israel
Prior art keywords
alkyl
renin inhibitors
peptidic renin
peptidic
halovinyl
Prior art date
Application number
IL88619A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL88619A0 publication Critical patent/IL88619A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Quinoline Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Fodder In General (AREA)
  • Cosmetics (AREA)
IL88619A 1987-12-15 1988-12-07 Non-peptidic renin inhibitors IL88619A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13237387A 1987-12-15 1987-12-15

Publications (1)

Publication Number Publication Date
IL88619A0 true IL88619A0 (en) 1989-07-31

Family

ID=22453720

Family Applications (1)

Application Number Title Priority Date Filing Date
IL88619A IL88619A0 (en) 1987-12-15 1988-12-07 Non-peptidic renin inhibitors

Country Status (27)

Country Link
EP (1) EP0321192B1 (xx)
JP (1) JPH0692366B2 (xx)
KR (1) KR900009022B1 (xx)
CN (1) CN1025676C (xx)
AT (1) ATE96433T1 (xx)
AU (1) AU593181B2 (xx)
CA (1) CA1314545C (xx)
CS (1) CS274671B2 (xx)
DD (1) DD283381A5 (xx)
DE (1) DE3885252T2 (xx)
DK (1) DK694888A (xx)
EG (1) EG18927A (xx)
ES (1) ES2059540T3 (xx)
FI (1) FI88295C (xx)
HU (1) HU201564B (xx)
IE (1) IE61548B1 (xx)
IL (1) IL88619A0 (xx)
MX (1) MX14210A (xx)
MY (1) MY104354A (xx)
NO (1) NO172935C (xx)
NZ (1) NZ227322A (xx)
PH (1) PH26974A (xx)
PL (1) PL152507B1 (xx)
PT (1) PT89210B (xx)
SU (1) SU1651786A3 (xx)
YU (1) YU46686B (xx)
ZA (1) ZA889307B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2638747B1 (fr) * 1988-11-08 1993-12-24 Synthelabo Derives de phenyloxypropanolamines, leur preparation et leur application en therapeutique
AU622330B2 (en) * 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
DE4035846A1 (de) * 1990-11-10 1991-06-06 Kuntze Angelgeraete Dam Angelrolle mit spule zur aufnahme der angelschnur
EP0966443B1 (en) * 1997-02-26 2009-01-28 Pfizer Inc. Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor
EP1498417A1 (en) * 2000-02-04 2005-01-19 Pfizer Products Inc. Heterocyclic amide derivatives
NZ520075A (en) * 2000-02-04 2004-02-27 Pfizer Prod Inc Heterocyclic amide derivatives
US20040097554A1 (en) * 2002-10-30 2004-05-20 Pfizer Inc Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents
US7405210B2 (en) 2003-05-21 2008-07-29 Osi Pharmaceuticals, Inc. Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
DE602004028122D1 (de) * 2003-05-21 2010-08-26 Prosidion Ltd Pyrrolopyridin-2-carbonsäuren als hemmer der glycogenphosphorylase
CN108164528B (zh) * 2018-03-31 2019-03-22 杭州巴洛特生物科技有限公司 一种酰胺类衍生物及其在高血压、高血脂和动脉粥样硬化中的应用
CN108218865B (zh) * 2018-03-31 2020-06-26 济南市儿童医院 一种酰胺类衍生物及其在心脑血管方面的应用
CN108456207B (zh) * 2018-03-31 2020-11-20 浙江药苑生物科技有限公司 一种酰胺类衍生物及其在心脑血管方面的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0181110A3 (en) * 1984-10-22 1988-05-11 Kissei Pharmaceutical Co. Ltd. Histidine derivatives as renin inhibitors
US4727060A (en) * 1984-11-13 1988-02-23 Ciba-Geigy Corporation Novel 5-amino-4-hydroxyvaleryl derivatives

Also Published As

Publication number Publication date
HUT48277A (en) 1989-05-29
NZ227322A (en) 1990-06-26
YU46686B (sh) 1994-04-05
DE3885252D1 (de) 1993-12-02
DK694888A (da) 1989-08-11
ATE96433T1 (de) 1993-11-15
NO885549D0 (no) 1988-12-14
ES2059540T3 (es) 1994-11-16
EP0321192B1 (en) 1993-10-27
HU201564B (en) 1990-11-28
MY104354A (en) 1994-03-31
DK694888D0 (da) 1988-12-14
FI88295C (fi) 1993-04-26
JPH0692366B2 (ja) 1994-11-16
CN1025676C (zh) 1994-08-17
FI88295B (fi) 1993-01-15
IE61548B1 (en) 1994-11-16
CA1314545C (en) 1993-03-16
SU1651786A3 (ru) 1991-05-23
EP0321192A2 (en) 1989-06-21
PH26974A (en) 1992-12-28
PL276363A1 (en) 1989-08-07
IE883731L (en) 1989-06-15
JPH01250345A (ja) 1989-10-05
CS820388A2 (en) 1990-10-12
YU225788A (en) 1990-04-30
NO172935C (no) 1993-09-29
CN1034366A (zh) 1989-08-02
PL152507B1 (en) 1991-01-31
AU2688188A (en) 1989-06-15
MX14210A (es) 1993-05-01
DE3885252T2 (de) 1994-02-17
EP0321192A3 (en) 1991-01-30
FI885783A0 (fi) 1988-12-14
AU593181B2 (en) 1990-02-01
PT89210B (pt) 1993-09-30
NO885549L (no) 1989-06-16
EG18927A (en) 1996-03-31
PT89210A (pt) 1989-12-29
ZA889307B (en) 1990-08-29
KR900009022B1 (ko) 1990-12-17
DD283381A5 (de) 1990-10-10
FI885783A (fi) 1989-06-16
KR890009867A (ko) 1989-08-04
NO172935B (no) 1993-06-21
CS274671B2 (en) 1991-09-15

Similar Documents

Publication Publication Date Title
EG18927A (en) Non-peptidic renin inhibitors
PL352413A1 (en) Quinoline derivatives as inhibitors of mek enzymes
MX9700308A (es) Derivados heterobiciclicos.
GB2263110B (en) Piperazine derivatives
BG105254A (en) Heterocyclic compounds as inhibitors of rotamase enzymes
TW368501B (en) 7-(2-aminoethyl)-benzothiazolones
EP0815859A4 (en) INTIMATE THICKENING INHIBITORS
CA2142700A1 (en) 3-oxo-pyrido(1,2-a)benzimidazole-4-carboxyl and 4-oxo-azepino(1,2-a)benzimidazole-5-carboxyl derivatives useful in treating central nervous system disorders
EP0885891A4 (en) ISOXAZOLE DERIVATIVES
BG105855A (en) 2-aminopyridines containing fused ring substituents
DK165247C (da) 2,3,4,5-substituerede 1,6-naphthyridinderivater, deres fremstilling samt anvendelse af disse til fremstilling af laegemidler til bekaempelse af cardiale, cerebrale og perifere karlidelser, myocardial iskaemi, cerebral infarkt, lungethrombose, stenoser, arterioscleroser og hjerte-kredsloebslidelser og laegemiddel indeholdende disse derivater
ES2187063T3 (es) Derivados de azetidinona para el tratamiento de infecciones por hcmv.
BG103554A (en) Substituted pyrazol-3-ylbenzazoles
EP0301873A3 (en) 2'-deoxy-5-fluorouridine derivatives
NZ238238A (en) 5h,10h-pyrido(3,4-b)pyrrolo(1,2-e)(1,4,5)oxadiazepine derivatives and pharmaceutical compositions thereof having analgesic activity
SG49234A1 (en) Condensed heterocyclic glutamic acid derivatives as antiproliferative agents
ES8308568A1 (es) Un procedimiento para la preparacion de nuevos derivados del 1,1-dioxido del acido penicilanico.
CA1264500C (en) N SUBSTITUTION DERIVATIVES OF AMIDO-AMINO-ACIDS

Legal Events

Date Code Title Description
RH Patent void